NUK - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources NUK. For full access, REGISTER.

1 2 3 4 5
hits: 59
1.
  • Comparison of iodine-123 me... Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma
    Taggart, Denah R; Han, Myo M; Quach, Alekist ... Journal of clinical oncology, 11/2009, Volume: 27, Issue: 32
    Journal Article
    Peer reviewed
    Open access

    Children with relapsed neuroblastoma have poor survival. It is crucial to have a reliable method for evaluating functional response to new therapies. In this study, we compared two functional imaging ...
Full text

PDF
2.
  • Phase I trial of fenretinid... Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium
    Maurer, Barry J.; Kang, Min H.; Villablanca, Judith G. ... Pediatric blood & cancer, November 2013, Volume: 60, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    Background A phase I study was conducted to determine the maximum‐tolerated dose, dose‐limiting toxicities (DLTs), and pharmacokinetics of fenretinide (4‐HPR) delivered in an oral powderized lipid ...
Full text

PDF
3.
  • Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings
    Hu, Houchun Harry; Chung, Sandra A; Nayak, Krishna S ... Journal of computer assisted tomography, 01/2011, Volume: 35, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    This study investigates differences in computed tomography Hounsfield units between metabolically active (brown fat) and inactive adipose tissues (white fat) due to variations in their densities. ...
Check availability


PDF
4.
  • Phase I trial of oral irino... Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study
    Wagner, Lars M; Villablanca, Judith G; Stewart, Clinton F ... Journal of clinical oncology, 03/2009, Volume: 27, Issue: 8
    Journal Article
    Peer reviewed
    Open access

    Irinotecan and temozolomide have single-agent activity and schedule-dependent synergy against neuroblastoma. Because protracted administration of intravenous irinotecan is costly and inconvenient, we ...
Full text

PDF
5.
Full text
6.
  • A phase I study of zoledron... A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study
    Russell, Heidi V.; Groshen, Susan G.; Ara, Tasnim ... Pediatric blood & cancer, August 2011, Volume: 57, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    Background Zoledronic acid, a bisphosphonate, delays progression of bone metastases in adult malignancies. Bone is a common metastatic site of advanced neuroblastoma. We previously reported efficacy ...
Full text

PDF
7.
  • PET imaging in pediatric ne... PET imaging in pediatric neuroradiology: current and future applications
    Kim, Sunhee; Salamon, Noriko; Jackson, Hollie A. ... Pediatric radiology, 2010/1, Volume: 40, Issue: 1
    Journal Article
    Peer reviewed

    Molecular imaging with positron emitting tomography (PET) is widely accepted as an essential part of the diagnosis and evaluation of neoplastic and non-neoplastic disease processes. PET has expanded ...
Full text
8.
  • Abnormal Development of Tha... Abnormal Development of Thalamic Microstructure in Premature Neonates with Congenital Heart Disease
    Paquette, Lisa B.; Votava-Smith, Jodie K.; Ceschin, Rafael ... Pediatric cardiology, 06/2015, Volume: 36, Issue: 5
    Journal Article
    Peer reviewed
    Open access

    Preterm birth is associated with alteration in corticothalamic development, which underlies poor neurodevelopmental outcomes. Our hypothesis was that preterm neonates with CHD would demonstrate ...
Full text

PDF
9.
  • Time to disease progression... Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621)
    Fox, Elizabeth; Mosse', Yael P.; Meany, Holly M. ... Pediatric blood & cancer, June 2014, Volume: 61, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    Background ABT‐751, an orally bioavailable sulfonamide binds the colchicine site of beta‐tubulin and inhibits microtubule polymerizaton. Prior phase I studies established the recommended dose in ...
Full text

PDF
10.
  • Delayed diagnosis of injuri... Delayed diagnosis of injuries in pediatric trauma: the role of radiographic ordering practices
    Willner, Emily L., MD; Jackson, Hollie A., MD; Nager, Alan L., MD, MHA The American journal of emergency medicine, 2012, 2012-Jan, 2012-1-00, 20120101, Volume: 30, Issue: 1
    Journal Article
    Peer reviewed

    Abstract Objectives We sought to describe the use of radiographic studies in pediatric major trauma patients and determine the extent to which a selective, clinically guided use of imaging ...
Full text
1 2 3 4 5
hits: 59

Load filters